Apple Inc. (AAPL), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Among AQR Capital Management’s Top Q2 Picks

AQR Capital Management, managed by Cliff Asness, recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014. The fund revealed more than 2,000 positions, with a market value of $37.1 billion. The second-quarter equity portfolio is focused on technology, healthcare and financial stocks, which account for about 50% of the total value. Let’s discuss top three largest holdings from the AQR Capital’s portfolio for the second quarter.

AQR CAPITAL MANAGEMENT

On the top position is Apple Inc. (NASDAQ:AAPL), in which AQR Capital disclosed ownership of 4.95 million shares, with a reported value of $459.6 million. Previously, the fund reported holding 530,859 shares of the company. In its recent 13F filing, Icahn Enterprises LP, led by activist investor Carl Icahn, revealed holding 52 million shares of Apple Inc. (NASDAQ:AAPL), with a market value of $4.9 billion. Leon Cooperman of Omega Advisors reported acquiring 1.26 million shares of Apple Inc. (NASDAQ:AAPL) in the second quarter. Other investors, including Harris Associates and Ken Fisher’s Fisher Asset Management, also disclosed big stakes in Apple Inc. (NASDAQ:AAPL).

The second most valuable holding is Johnson & Johnson (NYSE:JNJ). AQR Capital reported owning 3.64 million shares, worth $381.3 million of the company. At the end of first quarter, the fund held 3.61 million shares of the company. For the second quarter of 2014, Johnson & Johnson (NYSE:JNJ) reported net earnings of $4.3 billion, or $1.51 diluted earnings per share, compared to net earnings of $3.8 billion, or $1.33 diluted earnings per share, om the same period of last year. Other hedge funds holding large stakes in the company include Ken Fisher’s Fisher Asset Management, which owns 10.49 million shares, worth $1.1 billion, and Yacktman Asset Management, run by Donald Yacktman, which disclosed holding a $946.4 million stake, containing 9.05 million shares of Johnson & Johnson (NYSE:JNJ).

Next is Pfizer Inc. (NYSE:PFE), in which AQR Capital reported holding 10.40 million shares, with a reported value of $308.5 million. The stake represents an increase from 9.45 million shares the fund held previously. Last month, Pfizer Inc. (NYSE:PFE) announced that it agreed to acquire InnoPharma Inc., a privately-held pharmaceutical development company. The deal is expected to occur during the third quarter. At the end of last month, Pfizer Inc. (NYSE:PFE) reported that it signed an agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million, and the transaction is subject to customary closing conditions as well as regulatory approvals in several markets, according to a press release.

Other significant shareholders of Pfizer Inc. (NYSE:PFE) include Irving Kahn’s Kahn Brothers, and Sanborn Kilcollin Partners LLC, led by Robert Sanborn and Rick Kilcollin, holding 2.12 million shares, and 446,696 shares, respectively.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!